Periodic Reporting for period 4 - ContraNPM1AML (Dissecting to hit the therapeutic targets in nucleophosmin (NPM1)-mutated acute myeloid leukemia)

Summary
Acute myeloid leukemias (AML) is an aggressive hematological malignancy most commonly affecting elderly population and an unmet medical need. AML with nucleophosmin (NPM1) gene mutations is a new well recognized entity in the World Organization of Health (WHO) classification...
More information & hyperlinks